Virtus Investment Advisers’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
261,322
+187,423
+254% +$810K 0.35% 120
2026
Q1
$286K Buy
73,899
+1,804
+3% +$7.4K 0.08% 287
2025
Q4
$301K Buy
+72,095
New +$279K 0.08% 254

Other funds holding PGEN

Virtus Investment Advisers's PGEN Position: Q2 2026 in Review

Virtus Investment Advisers increased its Precigen (PGEN) stake by 254% in Q2 2026, buying an estimated $810K and bringing the position to 261,322 shares worth $1.49M. The position accounts for 0.35% of the portfolio, ranked #120.

Virtus Investment Advisers first reported a position in PGEN in Q4 2025 and has held it in 3 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Virtus Investment Advisers held 261,322 shares of Precigen worth $1.49M as of Q2 2026.
  • Virtus Investment Advisers bought 187,423 Precigen shares in Q2 2026, an estimated $810K.
  • Precigen made up 0.35% of Virtus Investment Advisers's portfolio in Q2 2026, its #120 holding.
  • Virtus Investment Advisers first reported a position in Precigen in Q4 2025 and has held it in 3 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.